We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might h...
Read ArticleLiving Cell Technologies (LCT) is partnering with La Trobe University to conduct multiple pre-clinic...
Read ArticleLiving Cell Technologies (ASX: LCT) has entered into a research agreement with Melbourne’s La Trobe...
Read ArticleFutures are predicting that the ASX will open in the red to end the week, bucking the trend on a wee...
Read ArticleASX to open lower today after a late selloff on Wall Street The US Fed’s preferred inflation posted...
Read ArticleMelbourne-headquartered biotechnology company Living Cell Technologies (ASX: LCT) made significant s...
Read ArticleThis content is created by Smallcaps Authors. [Author : Imelda Cotton] Living Cell Technologies (A...
Read ArticleThis content is created by Smallcaps Authors. [Author : Colin Hay] Biotechnology company Living Ce...
Read ArticleAVITA receives US FDA premarket approval for its RECELL System Living Cell falls after saying it wi...
Read ArticleThis content is created by Smallcaps Authors. [Author : Imelda Cotton] Living Cell Technologies (A...
Read ArticleThis content is created by Smallcaps Authors. [Author : Imelda Cotton] Biotechnology company Livin...
Read ArticleLiving Cell Technologies (LCT) launches a $2.5 million capital raise with Alignment Capital to devel...
Read ArticleThe ASX fell today because US data gave Wall Street the willies on Friday A month’s worth of shippi...
Read ArticleWall Street slump leads the ASX into an early morning drop. Thanks, Obama Benchmark strides deeper...
Read ArticleLiving Cell Technologies (LCT) completes stage one of its use of artificial intelligence in the plan...
Read ArticleActing out your dreams could be a sign of a neurological disease, a study finds ASX-listed Pharmaxi...
Read ArticleLiving Cell Technologies (ASX:LCT) has advanced its Parkinson’s disease research with choroi...
Read ArticleHighlights The healthcare sector comprises stocks from diversified backgrounds, including health...
Read ArticleBiotech company Living Cell Technologies (LCT) raises $1.285 million through a private placement to...
Read ArticleLiving Cell Technologies (LCT) enters a trading halt as the company awaits more details in regards...
Read ArticleLiving Cell Technologies (ASX:LCT) says artificial intelligence will be applied to its resea...
Read ArticleHighlights LCT has marked a major leap in its groundbreaking research to combat Parkinson’s dise...
Read ArticleOneview extends supply deal to BJC’s hospital beds LCT will start to use artificial intelligence in...
Read ArticleASX to open the lower on the first day of the new Labor government Experts say there will be renewe...
Read ArticleBiotech sector has had a tough time recently But there are signs of things improving this year A lo...
Read ArticleLiving Cell Technologies (ASX:LCT) says it has advanced plans for a third clinical trial of...
Read ArticleHighlights The Australian healthcare sector includes companies engaged in biotechnology and rese...
Read ArticleThe ASX 200 Health Index (XHJ) is falling by 0.3% at the time of writing, compared to the broader in...
Read ArticleLiving Cell Technologies (LCT) receives valid applications for new shares and new options under its...
Read ArticleThere were few major catalysts on Thursday, as the ASX traded flat in a relatively cruisy session fo...
Read ArticleToday is the deadline for ASX companies to submit their quarterlies. Stockhead has recapped the Top...
Read ArticleJust like yesterday the ASX rallied for most of the day but retreated in the afternoon and today clo...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleLiving Cell Technologies (LCT) secures funding for its third clinical trial of NTCELL in Parkinson’...
Read ArticleThe ASX saw a frenzy of M&A deals today and it sent the market higher. Companies completing deal...
Read ArticleIt’s been a mixed week for the ASX but it has finished on a high. The ASX 200 closed 0.69% higher th...
Read ArticleSummary Diagnostics company Rhythm Biosciences has confirmed that LRF enhancements have shown to...
Read ArticleIt is with sorrow that AusBiotech acknowledges the passing of Living Cell Technologies (LCT)...
Read ArticleThe sudden drop in spot gold prices and reintroduction of COVID-19 restrictions in New Zealand have...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleA quick wrap of the key winners and losers on Monday, July 6. Data is taken after the market closes...
Read ArticleA quick wrap of the key winners and losers on Friday, July 3. Data is taken after the market closes...
Read ArticleA quick wrap of the key winners and losers on Monday, June 22. Data is taken after the market closes...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleInvestment bank Lazard believes shareholder activism is going to become more rife in future. Shareho...
Read ArticleGenerally, stocks are bifurcated into four categories based on their market capitalization: Large ca...
Read ArticleThere are no shortage of small cap health and biotech companies listed on the ASX — around 140 or so...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleStockhead’s Top 10 at 10 highlights the best (and the worst) performing ASX small caps in morning tr...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
